ABBV-744 CANCER TREATMENT CLINICAL TRIALS - AN OVERVIEW

In Segment A, contributors will get unique doses and schedules of oral ABBV-744 pill to determine Secure dosing program. More members is going to be enrolled on the identified monotherapy dosign program. In Phase B, participants will get oral ruxolitinib and ABBV-744 is going to be provided as "incorporate-on" therapy. In Section C, contributors wi